Oscar Health price to free cash flow OSCR
Market value divided by free cash flow over the last twelve months, since 2022.
- Today, Oct 23, 2026
- 2.2×
- 4-year median
- 4.1×
- Against its 4-year history
- 4th
- percentile: 0 is its lowest day, 100 its highest
- 4-year range
- 2.0× to 35.6×
- Peer median
- 15.2×
Oscar Health's price to free cash flow is 2.2× as of Oct 23, 2026.
That is below its 4-year median of 4.1×, lower than on 96% of days in the last 4 years.
Over that time it ranged from 2.0× in Aug 2026 to 35.6× in May 2022.
The median for 6 health insurers of a similar size is 15.2×.
Price to free cash flow over time
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 2.2× | 2.0× | 6.4× |
| 2025 | 5.4× | 2.9× | 6.5× |
| 2024 | 3.8× | 3.7× | 21.9× |
| 2023 | 8.3× | 2.1× | 10.8× |
| 2022 | 2.3× | 2.0× | 35.6× |
Against its peers
Companies in Medical - Healthcare Plans nearest Oscar Health's size, closest first, today.
| Company | Price to free cash flow |
|---|---|
| OSCROscar Health | 2.2× |
| CNCCentene | 3.9× |
| HUMHumana | 26.0× |
| ALHCAlignment Healthcare | 9.4× |
| TRUPTrupanion | 15.7× |
| CICigna | n/m |
| ELVElevance Health | 15.2× |
| Peer median | 15.2× |
What the price to free cash flow tells you
Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.
Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.
More on Oscar Health
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.